Fenofibrate 43mg Capsules

Manufacturer APOTEX Active Ingredient Fenofibrate and Derivatives Capsules(fen oh FYE brate & dah RIV ah tives) Pronunciation fen oh FYE brate
It is used to lower bad cholesterol, lower triglycerides, and raise good cholesterol (HDL).
🏷️
Drug Class
Antilipemic Agent
🧬
Pharmacologic Class
Peroxisome Proliferator-Activated Receptor Alpha (PPARΞ±) Agonist; Fibrate
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Jul 2004
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Fenofibrate is a medication used to help lower high levels of triglycerides (a type of fat) and cholesterol in your blood. It works by helping your body break down and remove these fats more effectively. It's often used along with diet changes and exercise to improve your lipid levels and reduce the risk of heart problems.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To ensure you get the most out of your medication, follow these steps:

Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
Check with your pharmacist to see if your specific brand of medication should be taken with food or can be taken with or without food.
If you have difficulty swallowing, consult with your doctor for guidance.
Take your medication with a full glass of water.
If you are taking cholestyramine or colestipol, be sure to take them at least 4 hours before or 1 hour after your medication.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel better.

Important Administration Instructions

Swallow your medication whole; do not chew, crush, open, or dissolve it.

Storing and Disposing of Your Medication

Store your medication at room temperature with the lid tightly closed.
Some brands of medication must be stored in their original container. Do not remove the anti-moisture cube or packet. If you are unsure, consult with your doctor or pharmacist.

What to Do If You Miss a Dose

If you miss a dose, skip it and resume your regular dosing schedule.
Do not take more than one dose in a 24-hour period, unless your doctor instructs you to do so.
πŸ’‘

Lifestyle & Tips

  • Continue to follow a low-fat, low-cholesterol diet as recommended by your doctor or dietitian.
  • Engage in regular physical activity as advised by your healthcare provider.
  • Maintain a healthy weight.
  • Limit alcohol intake, as it can increase triglyceride levels.
  • Quit smoking, as it negatively impacts cardiovascular health.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 43 mg orally once daily with meals
Dose Range: 43 - 130 mg

Condition-Specific Dosing:

Hypertriglyceridemia: Initial: 43 mg once daily with meals. Max: 130 mg once daily.
Primary Hypercholesterolemia or Mixed Dyslipidemia: Initial: 130 mg once daily with meals. Max: 130 mg once daily.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: CrCl 50-80 mL/min: No dose adjustment needed, but monitor renal function.
Moderate: CrCl 30-49 mL/min: Initial dose 43 mg every other day. Max dose 43 mg every other day. Avoid if CrCl < 30 mL/min.
Severe: CrCl < 30 mL/min: Contraindicated.
Dialysis: Contraindicated in end-stage renal disease (ESRD) including patients on dialysis.

Hepatic Impairment:

Mild: Use with caution; monitor liver function.
Moderate: Use with caution; monitor liver function.
Severe: Contraindicated in active liver disease, including primary biliary cirrhosis and unexplained persistent liver function abnormalities.

Pharmacology

πŸ”¬

Mechanism of Action

Fenofibrate is a prodrug that is rapidly hydrolyzed to its active metabolite, fenofibric acid. Fenofibric acid activates peroxisome proliferator-activated receptor alpha (PPARΞ±), a nuclear receptor that regulates lipid metabolism. Through activation of PPARΞ±, fenofibric acid increases lipolysis and elimination of triglyceride-rich particles from plasma by activating lipoprotein lipase and reducing production of apolipoprotein C-III (an inhibitor of lipoprotein lipase activity). It also increases the synthesis of apolipoproteins A-I and A-II, which are components of HDL-C.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Increased with food (Lipofen 43mg has improved absorption compared to other formulations, especially when taken with food).
Tmax: 4-5 hours (for fenofibric acid)
FoodEffect: Absorption is increased when taken with food. The 43mg capsule is designed to be taken with meals.

Distribution:

Vd: Not available (for fenofibric acid, but extensively distributed)
ProteinBinding: Approximately 99% (to plasma albumin)
CnssPenetration: Limited

Elimination:

HalfLife: Approximately 20 hours (for fenofibric acid)
Clearance: Not available
ExcretionRoute: Mainly renal (60-70% as fenofibric acid and its glucuronide conjugate); fecal (25%)
Unchanged: Less than 1% (of fenofibric acid in urine)
⏱️

Pharmacodynamics

OnsetOfAction: Within days to weeks for lipid-lowering effects
PeakEffect: Typically within 2-4 weeks for maximum lipid-lowering effect
DurationOfAction: Maintained with daily dosing

Safety & Warnings

⚠️

Side Effects

Important Side Effects to Report to Your Doctor Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, seek medical attention immediately:

Allergic reactions: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat. In rare cases, allergic reactions can be life-threatening.
Liver problems: Dark urine, tiredness, decreased appetite, upset stomach or stomach pain, light-colored stools, vomiting, or yellow skin or eyes.
Pancreatitis: Severe stomach pain, severe back pain, or severe upset stomach or vomiting.
Gallstones: Sudden pain in the upper right belly area, right shoulder area, or between the shoulder blades, yellow skin or eyes, or fever with chills.
Severe joint pain or swelling: If you experience very bad joint pain or swelling, contact your doctor right away.
Blood clots: Chest pain or pressure, coughing up blood, shortness of breath, swelling, warmth, numbness, change of color, or pain in a leg or arm, or trouble speaking or swallowing.
Muscle problems: Muscle pain or weakness, especially if you feel very tired or weak or have a fever. This can also lead to kidney problems. Inform your doctor if you have difficulty urinating or notice a change in your urine output.
Severe skin reactions: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions, which can be life-threatening. Seek medical help immediately if you experience red, swollen, blistered, or peeling skin; red or irritated eyes; sores in your mouth, throat, nose, eyes, genitals, or any areas of skin; fever; chills; body aches; shortness of breath; or swollen glands.
Low blood cell counts: If blood cell counts get very low, this can lead to bleeding problems, infections, or anemia. Contact your doctor right away if you experience signs of infection like fever, chills, or sore throat; any unexplained bruising or bleeding; or if you feel very tired or weak.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or only have minor ones. If you experience any of the following side effects or any other side effects that bother you or do not go away, contact your doctor:

Headache
Back pain
Stomach pain

This is not an exhaustive list of all possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Unexplained muscle pain, tenderness, or weakness, especially if accompanied by fever or dark urine (signs of muscle breakdown).
  • Severe stomach pain, with or without nausea and vomiting (signs of pancreatitis or gallstones).
  • Yellowing of the skin or eyes (jaundice), dark urine, or unusual tiredness (signs of liver problems).
  • Unusual bleeding or bruising (especially if taking blood thinners).
  • Signs of kidney problems, such as swelling in your ankles or feet, or changes in urination.
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, such as gallbladder disease, kidney disease, liver disease, or elevated liver enzymes.
If you are taking any of the following medications: atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, or simvastatin.
If you are breastfeeding or plan to breastfeed. Note that you should not breastfeed while taking this medication, and you may need to avoid breastfeeding for 5 days after your last dose. Consult your doctor to determine the best course of action.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help you verify that it is safe to take this medication with your other medications and health conditions. Do not start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood work and laboratory tests should be conducted as directed by your doctor to monitor your condition. Adhere to the diet and exercise plan recommended by your doctor to ensure optimal management of your health.

Be aware that this medication can cause liver problems, which in some cases may be severe and potentially life-threatening, requiring a liver transplant or resulting in death. If you have any concerns or questions, discuss them with your doctor.

If you are 65 years or older, exercise caution when using this medication, as you may be more susceptible to experiencing side effects.

If you are pregnant or planning to become pregnant, consult your doctor to discuss the potential benefits and risks associated with using this medication during pregnancy.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • No specific antidote or symptoms of overdose are well-defined. Symptoms may include exaggerated adverse effects such as muscle pain, liver enzyme elevations, or gastrointestinal upset.

What to Do:

In case of suspected overdose, contact a poison control center (1-800-222-1222) or seek emergency medical attention immediately. Treatment is generally supportive and symptomatic. Hemodialysis is not effective in removing fenofibric acid from the body.

Drug Interactions

🚫

Contraindicated Interactions

  • Cyclosporine (increased risk of renal dysfunction)
  • Colchicine (increased risk of myopathy/rhabdomyolysis)
πŸ”΄

Major Interactions

  • Statins (HMG-CoA reductase inhibitors) - increased risk of myopathy, rhabdomyolysis, and renal failure. Use with caution, monitor for muscle pain.
  • Oral anticoagulants (e.g., Warfarin) - potentiates anticoagulant effect, increased risk of bleeding. Reduce anticoagulant dose and monitor INR frequently.
  • Bile acid sequestrants (e.g., Cholestyramine, Colestipol) - may reduce absorption of fenofibrate. Administer fenofibrate 1 hour before or 4-6 hours after bile acid sequestrants.
🟑

Moderate Interactions

  • Fibrates (other) - concomitant use not recommended due to increased risk of adverse effects.
  • Glitazones (e.g., Pioglitazone, Rosiglitazone) - potential for additive effects on lipid parameters, monitor closely.
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Lipid Panel (Total Cholesterol, LDL-C, HDL-C, Triglycerides)

Rationale: To establish baseline lipid levels and assess treatment efficacy.

Timing: Prior to initiation of therapy.

Liver Function Tests (ALT, AST, ALP, Bilirubin)

Rationale: To assess baseline hepatic function and identify pre-existing liver disease, as fenofibrate can cause transaminase elevations.

Timing: Prior to initiation of therapy.

Renal Function (Serum Creatinine, eGFR)

Rationale: To assess baseline renal function, as fenofibrate is primarily renally eliminated and dose adjustments are required in renal impairment.

Timing: Prior to initiation of therapy.

Complete Blood Count (CBC)

Rationale: To assess for potential hematologic abnormalities (e.g., anemia, leukopenia) which have been reported.

Timing: Prior to initiation of therapy.

πŸ“Š

Routine Monitoring

Lipid Panel

Frequency: Every 4-8 weeks initially, then periodically (e.g., every 3-6 months) once lipid goals are achieved.

Target: Individualized based on patient risk factors and guidelines (e.g., Triglycerides < 150 mg/dL, LDL-C and HDL-C goals).

Action Threshold: Failure to achieve lipid goals, or significant adverse changes in lipid profile.

Liver Function Tests (ALT, AST)

Frequency: Every 3 months during the first 12 months of therapy, and periodically thereafter.

Target: Within normal limits.

Action Threshold: Persistent ALT or AST elevations > 3 times the upper limit of normal (ULN). Discontinue if elevations persist.

Renal Function (Serum Creatinine, eGFR)

Frequency: Periodically (e.g., every 6-12 months), or more frequently in patients with pre-existing renal impairment or risk factors.

Target: Stable, within patient's baseline range.

Action Threshold: Significant increase in serum creatinine or decrease in eGFR. Consider dose adjustment or discontinuation.

INR (if on Warfarin)

Frequency: More frequently (e.g., weekly) when initiating or discontinuing fenofibrate, then as clinically indicated.

Target: Therapeutic range for indication (e.g., 2.0-3.0 for atrial fibrillation).

Action Threshold: INR outside of therapeutic range; adjust warfarin dose accordingly.

πŸ‘οΈ

Symptom Monitoring

  • Unexplained muscle pain, tenderness, or weakness (especially if accompanied by fever or malaise) - indicative of myopathy/rhabdomyolysis.
  • Severe abdominal pain, nausea, vomiting - indicative of pancreatitis or gallstones.
  • Yellowing of skin or eyes (jaundice), dark urine, light-colored stools, persistent fatigue - indicative of liver injury.
  • Signs of bleeding (e.g., unusual bruising, nosebleeds, blood in urine/stools) - especially if on anticoagulants.

Special Patient Groups

🀰

Pregnancy

Fenofibrate is Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy should be considered only if the potential benefit justifies the potential risk to the fetus. Lipid-lowering drugs are generally not recommended during pregnancy as cholesterol and cholesterol derivatives are essential for fetal development.

Trimester-Specific Risks:

First Trimester: Potential for fetal harm, as organogenesis occurs. Avoid if possible.
Second Trimester: Limited data, but generally not recommended.
Third Trimester: Limited data, but generally not recommended.
🀱

Lactation

It is not known whether fenofibric acid is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Generally, breastfeeding is not recommended.

Infant Risk: L3 - Moderate risk. Potential for adverse effects on the infant, though data are limited.
πŸ‘Ά

Pediatric Use

Safety and effectiveness in pediatric patients have not been established. Use is generally not recommended.

πŸ‘΄

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Renal function should be monitored.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Fenofibrate 43mg (Lipofen) is a micronized formulation designed for improved absorption, especially when taken with food. It is not interchangeable on a mg-per-mg basis with other fenofibrate formulations (e.g., TriCor, Triglide) due to differences in bioavailability.
  • Always take fenofibrate 43mg capsules with meals to optimize absorption.
  • Regular monitoring of liver function tests (LFTs) and renal function is crucial, especially during the first year of therapy.
  • Educate patients on the signs and symptoms of myopathy (muscle pain, tenderness, weakness) and pancreatitis (severe abdominal pain) and to report them immediately.
  • Fenofibrate can potentiate the effects of warfarin; close INR monitoring and warfarin dose adjustment are necessary when initiating or discontinuing fenofibrate.
  • Not indicated for the primary prevention of cardiovascular disease, but rather for the treatment of dyslipidemia.
πŸ”„

Alternative Therapies

  • Other Fibrates (e.g., Gemfibrozil, Fenofibrate (other formulations like TriCor, Triglide))
  • HMG-CoA Reductase Inhibitors (Statins) (e.g., Atorvastatin, Rosuvastatin, Simvastatin) - primary for LDL-C lowering, but some also lower triglycerides.
  • Omega-3 Fatty Acid Esters (e.g., Icosapent ethyl, Omega-3-acid ethyl esters) - for severe hypertriglyceridemia.
  • PCSK9 Inhibitors (e.g., Alirocumab, Evolocumab) - primarily for LDL-C lowering.
  • Niacin (Nicotinic Acid) - for mixed dyslipidemia, but often limited by side effects.
  • Bempedoic Acid (with or without Ezetimibe) - for LDL-C lowering.
  • Diet and lifestyle modifications (cornerstone of dyslipidemia management).
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $30-$150 per 30 capsules (generic)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (for generic formulations)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the medication taken, the amount, and the time it occurred.